JP2022521460A5 - - Google Patents

Info

Publication number
JP2022521460A5
JP2022521460A5 JP2021544720A JP2021544720A JP2022521460A5 JP 2022521460 A5 JP2022521460 A5 JP 2022521460A5 JP 2021544720 A JP2021544720 A JP 2021544720A JP 2021544720 A JP2021544720 A JP 2021544720A JP 2022521460 A5 JP2022521460 A5 JP 2022521460A5
Authority
JP
Japan
Prior art keywords
cytidine
deaminase
nucleic acid
base editor
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021544720A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022521460A (ja
JP7600122B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/016288 external-priority patent/WO2020160517A1/en
Publication of JP2022521460A publication Critical patent/JP2022521460A/ja
Publication of JP2022521460A5 publication Critical patent/JP2022521460A5/ja
Priority to JP2024210915A priority Critical patent/JP7779988B2/ja
Application granted granted Critical
Publication of JP7600122B2 publication Critical patent/JP7600122B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021544720A 2019-01-31 2020-01-31 低減されたオフターゲット脱アミノ化を有する核酸塩基エディターおよび核酸塩基標的配列を改変するためのその使用方法 Active JP7600122B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024210915A JP7779988B2 (ja) 2019-01-31 2024-12-04 低減されたオフターゲット脱アミノ化を有する核酸塩基エディターおよび核酸塩基標的配列を改変するためのその使用方法

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962799702P 2019-01-31 2019-01-31
US62/799,702 2019-01-31
US201962835456P 2019-04-17 2019-04-17
US62/835,456 2019-04-17
US201962941569P 2019-11-27 2019-11-27
US62/941,569 2019-11-27
PCT/US2020/016288 WO2020160517A1 (en) 2019-01-31 2020-01-31 Nucleobase editors having reduced off-target deamination and methods of using same to modify a nucleobase target sequence

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024210915A Division JP7779988B2 (ja) 2019-01-31 2024-12-04 低減されたオフターゲット脱アミノ化を有する核酸塩基エディターおよび核酸塩基標的配列を改変するためのその使用方法

Publications (3)

Publication Number Publication Date
JP2022521460A JP2022521460A (ja) 2022-04-08
JP2022521460A5 true JP2022521460A5 (https=) 2023-02-03
JP7600122B2 JP7600122B2 (ja) 2024-12-16

Family

ID=71842357

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021544720A Active JP7600122B2 (ja) 2019-01-31 2020-01-31 低減されたオフターゲット脱アミノ化を有する核酸塩基エディターおよび核酸塩基標的配列を改変するためのその使用方法
JP2024210915A Active JP7779988B2 (ja) 2019-01-31 2024-12-04 低減されたオフターゲット脱アミノ化を有する核酸塩基エディターおよび核酸塩基標的配列を改変するためのその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024210915A Active JP7779988B2 (ja) 2019-01-31 2024-12-04 低減されたオフターゲット脱アミノ化を有する核酸塩基エディターおよび核酸塩基標的配列を改変するためのその使用方法

Country Status (8)

Country Link
US (1) US20220136012A1 (https=)
EP (1) EP3918077A4 (https=)
JP (2) JP7600122B2 (https=)
KR (1) KR20210124280A (https=)
CN (2) CN114072509B (https=)
AU (1) AU2020216484A1 (https=)
CA (1) CA3127494A1 (https=)
WO (1) WO2020160517A1 (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9228207B2 (en) 2013-09-06 2016-01-05 President And Fellows Of Harvard College Switchable gRNAs comprising aptamers
EP3592853A1 (en) 2017-03-09 2020-01-15 President and Fellows of Harvard College Suppression of pain by gene editing
EP3676376B1 (en) 2017-08-30 2025-01-15 President and Fellows of Harvard College High efficiency base editors comprising gam
US12406749B2 (en) 2017-12-15 2025-09-02 The Broad Institute, Inc. Systems and methods for predicting repair outcomes in genetic engineering
AU2019265019B2 (en) 2018-05-11 2025-11-06 Beam Therapeutics Inc. Methods of substituting pathogenic amino acids using programmable base editor systems
US12157760B2 (en) 2018-05-23 2024-12-03 The Broad Institute, Inc. Base editors and uses thereof
US12522807B2 (en) 2018-07-09 2026-01-13 The Broad Institute, Inc. RNA programmable epigenetic RNA modifiers and uses thereof
EP3847254A4 (en) 2018-09-07 2022-08-10 Beam Therapeutics Inc. COMPOSITIONS AND METHODS FOR DELIVERING A NUCLEOBASE EDITING SYSTEM
WO2020051562A2 (en) 2018-09-07 2020-03-12 Beam Therapeutics Inc. Compositions and methods for improving base editing
WO2020092453A1 (en) 2018-10-29 2020-05-07 The Broad Institute, Inc. Nucleobase editors comprising geocas9 and uses thereof
US12351837B2 (en) 2019-01-23 2025-07-08 The Broad Institute, Inc. Supernegatively charged proteins and uses thereof
AU2020215730A1 (en) 2019-01-31 2021-07-29 Beam Therapeutics Inc. Nucleobase editors having reduced non-target deamination and assays for characterizing nucleobase editors
CN120174005A (zh) 2019-02-13 2025-06-20 比姆医疗股份有限公司 具有用于修饰靶标序列中核碱基的腺苷脱氨酶碱基编辑器的经修饰的免疫细胞
WO2020191233A1 (en) 2019-03-19 2020-09-24 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
US12473543B2 (en) 2019-04-17 2025-11-18 The Broad Institute, Inc. Adenine base editors with reduced off-target effects
EP4034138A4 (en) 2019-09-27 2024-07-31 Beam Therapeutics, Inc. COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIQUID CANCERS
US12435330B2 (en) 2019-10-10 2025-10-07 The Broad Institute, Inc. Methods and compositions for prime editing RNA
US12416001B2 (en) * 2020-02-14 2025-09-16 Ohio State Innovation Foundation Nucleobase editors and methods of use thereof
IL297761A (en) 2020-05-08 2022-12-01 Broad Inst Inc Methods and compositions for simultaneously editing two helices of a designated double-helix nucleotide sequence
CA3196831A1 (en) 2020-09-25 2022-03-31 Beam Therapeutics Inc. Fratricide resistant modified immune cells and methods of using the same
EP4313118A4 (en) * 2021-03-26 2025-06-18 Beam Therapeutics Inc. ADENOSINE DEAMINASE VARIANTS AND THEIR USES
KR20240007651A (ko) * 2021-04-16 2024-01-16 빔 테라퓨틱스, 인크. 간세포의 유전적 변형
WO2022261509A1 (en) * 2021-06-11 2022-12-15 The Broad Institute, Inc. Improved cytosine to guanine base editors
US20240352439A1 (en) * 2021-09-03 2024-10-24 The University Of Chicago Polypeptides and methods for modifying nucleic acids
WO2023086953A1 (en) * 2021-11-11 2023-05-19 Beam Therapeutics Inc. Compositions and methods for the treatment of hereditary angioedema (hae)
CN114686456B (zh) * 2022-05-10 2023-02-17 中山大学 基于双分子脱氨酶互补的碱基编辑系统及其应用
EP4540378A1 (en) * 2022-06-20 2025-04-23 CRISPR Therapeutics AG Base editing proteins and uses thereof
EP4605542A1 (en) * 2022-10-19 2025-08-27 DNA Script Methods and products for removal of uracil containing polynucleotides
CN117384885B (zh) 2022-12-15 2025-06-10 中国科学院遗传与发育生物学研究所 一种碱基编辑器及其应用
CN118475691B (zh) * 2023-02-28 2025-07-22 锐正基因(苏州)有限公司 用于碱基编辑的脱氨酶
WO2024240223A1 (en) 2023-05-24 2024-11-28 Accuredit Therapeutics (Suzhou) Co., Ltd. Deaminases and variants thereof for use in base editing
CN117210445A (zh) * 2023-08-29 2023-12-12 苏州湃芮生物科技有限公司 一种基于rna特异性脱氨酶突变体及其应用
CN120813698A (zh) * 2023-09-22 2025-10-17 北京大学现代农业研究院 改进的基因组编辑方法
WO2025119306A1 (zh) * 2023-12-06 2025-06-12 北京齐禾生科生物科技有限公司 优化工程化t细胞的碱基编辑系统及其应用
WO2025202473A1 (en) * 2024-03-28 2025-10-02 Revvity Discovery Limited A nucleic acid deaminase, a base editor and uses thereof
WO2025240372A1 (en) * 2024-05-13 2025-11-20 Metagenomi, Inc. Compositions and methods for editing t cells

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150165054A1 (en) * 2013-12-12 2015-06-18 President And Fellows Of Harvard College Methods for correcting caspase-9 point mutations
IL310721B2 (en) * 2015-10-23 2025-11-01 Harvard College Nucleobase editors and uses thereof
CN110214183A (zh) * 2016-08-03 2019-09-06 哈佛大学的校长及成员们 腺苷核碱基编辑器及其用途
KR20240116572A (ko) * 2017-03-23 2024-07-29 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 핵산 프로그램가능한 dna 결합 단백질을 포함하는 핵염기 편집제
WO2018213726A1 (en) * 2017-05-18 2018-11-22 The Broad Institute, Inc. Systems, methods, and compositions for targeted nucleic acid editing
EP3630849A4 (en) * 2017-05-25 2021-01-13 The General Hospital Corporation BIPARTITE BASIC EDITOR (BBE) AND TYPE II-C-CAS9 ZINC FINGER EDITOR ARCHITECTURES
WO2019084062A1 (en) * 2017-10-23 2019-05-02 The Broad Institute, Inc. SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETED NUCLEIC ACID EDITION
CN119570787A (zh) * 2018-05-11 2025-03-07 比姆医疗股份有限公司 使用可编程碱基编辑器系统遏止病原性突变的方法
US12157760B2 (en) * 2018-05-23 2024-12-03 The Broad Institute, Inc. Base editors and uses thereof
CA3108281A1 (en) * 2018-08-03 2020-02-06 Beam Therapeutics Inc. Multi-effector nucleobase editors and methods of using same to modify a nucleic acid target sequence
EP3911735A4 (en) * 2019-01-16 2023-07-12 Beam Therapeutics, Inc. MODIFIED IMMUNE CELLS WITH INCREASED ANTINEOPLASTIC ACTIVITY AND RESISTANCE TO IMMUNOSUPPRESSION

Similar Documents

Publication Publication Date Title
JP2022521460A5 (https=)
JP2025041661A5 (https=)
CN111065647B (zh) 用于提高碱基编辑精度的融合蛋白
Barreto et al. AID from bony fish catalyzes class switch recombination
MOCHIZUKI et al. Characterization of a plant SINE, p-SINE1, in rice genomes
US20240209332A1 (en) Enzymes with ruvc domains
Navaratnam et al. An overview of cytidine deaminases
KR20200121782A (ko) 아데노신 염기 편집제의 용도
AU2024219447A1 (en) Nucleobase editors and uses thereof
KR102515049B1 (ko) Cas9 변이체 및 그의 용도
Bresson et al. Lesion bypass in yeast cells: Pol η participates in a multi‐DNA polymerase process
JP2023052051A5 (https=)
JP2020164529A (ja) 遺伝子編集用のcas多様体
CN112979821B (zh) 一种提高基因编辑效率的融合蛋白及其应用
JP2016165307A5 (https=)
CN114438110B (zh) 一种精确无pam限制的腺嘌呤碱基编辑器及其构建方法
US12435323B2 (en) Enzymes with RUVC domains
JP2022532139A5 (https=)
CN112048497B (zh) 一种新型的单碱基编辑技术及其应用
US12312619B2 (en) Deaminases and variants thereof for use in base editing
Li et al. Nucleases in gene-editing technologies: past and prologue
JP2021522825A5 (https=)
Bonavita et al. The evolutionary conservation of rps3 introns and rps19-rps3-rpl16 gene cluster in Adiantum capillus-veneris mitochondria
WO2025119385A1 (zh) 一种具有三碱基编辑功能的融合蛋白及其应用
EP4209588A1 (en) Method for editing target dna, method for producing cell having edited target dna, and dna edition system for use in said methods